Demographic Impact of HIV/AIDS

Studies relating to AIDS are unanimous that the disease leads to reduced life expectancy. Higher female and child mortality rates are a distinct possibility. Medicines that have been developed to treat people affected with AIDS are very expensive and hence not suitable for low-income countries. Vaccines cannot be invented quickly because some people must get affected and then recover 10 facilitate the manufacture of the vaccine. Here there is no patient who has recovered. The World Bank initiative in developing a remedial vaccine is commendable in the sense that it has already announced a pre-committed price and liberal grant to the pharmaceutical company that can come up with the vaccine first.